ijms-logo

Journal Browser

Journal Browser

Redox Signaling in Metabolic and Age-Related Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (31 January 2020) | Viewed by 14382

Special Issue Editor


E-Mail Website
Guest Editor
Vascular Biology Center, Department of Medicine, Cardiology, Medical College of Georgia at Augusta University, Augusta, GA, USA
Interests: reactive oxygen species; redox signaling; vascular endothelial growth factor; angiogenesis; endothelial cells; peripheral arterial disease; diabetes
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Reactive oxygen species (ROS) play a dual role, as both deleterious and beneficial species. Indeed, ROS function as signalling molecules to mediate physiological responses, such as gene expression, cell proliferation and migration, as well as pathological responses, such as cellular senescence and apoptosis. ROS levels are determined by the balance between ROS generating systems, such as NADPH oxidase and mitochondria, as well as antioxidant defences, such as superoxide dismutase, catalase, and glutathione peroxidase. ROS are associated with metabolic diseases and aging, which are altered by the impairment of redox balance. ROS-mediated cell signalling (redox signalling) is primarily mediated through protein thiol oxidation and their dysregulations contribute to the development of metabolic, inflammation and age-related diseases such as diabetes mellitus, metabolic syndromes, atherosclerosis, and neurodegenerative diseases. Thus, understanding of specific sources of ROS production and how ROS signaling influences metabolic responses, such as mitochondria function, autophagy, metabolic gene expression, proteasome responses and inflammation including senescence-associated secretory phenotype (SASP) may lead to treat metabolic and age-related diseases. Moreover, it is important to identify the biological and (patho)physiological consequences of oxidative protein modifications and understand how they integrate and cross-talk with other signalling events in these diseases, which will develop therapeutic targets.

This Special Issue calls for papers coming from all over the world. Original studies, up-to-date/comprehensive review articles, and commentaries are all welcome.

Prof. Dr. Masuko Ushio-Fukai
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • reactive oxygen species
  • redox signaling
  • metabolic disease
  • aging
  • NADPH oxidase
  • mitochondria
  • antioxidants
  • thiol oxidation
  • inflammation

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 575 KiB  
Article
Systemic Oxidative Stress Is Increased in Postmenopausal Women and Independently Associates with Homocysteine Levels
by Arno R. Bourgonje, Amaal Eman Abdulle, Areej M. Al-Rawas, Muna Al-Maqbali, Mohsin Al-Saleh, Marvin B. Enriquez, Sultan Al-Siyabi, Khamis Al-Hashmi, Intisar Al-Lawati, Marian L. C. Bulthuis, Douwe J. Mulder, Sanne J. Gordijn, Harry van Goor and Jumana Saleh
Int. J. Mol. Sci. 2020, 21(1), 314; https://doi.org/10.3390/ijms21010314 - 02 Jan 2020
Cited by 34 | Viewed by 5957
Abstract
Oxidative stress plays a pivotal role in the pathogenesis of cardiovascular diseases (CVD). Postmenopausal women have an increased risk of developing CVD due to decreased estrogen availability, which is accompanied by increased oxidative stress. Serum free thiols (R-SH) provide a robust and powerful [...] Read more.
Oxidative stress plays a pivotal role in the pathogenesis of cardiovascular diseases (CVD). Postmenopausal women have an increased risk of developing CVD due to decreased estrogen availability, which is accompanied by increased oxidative stress. Serum free thiols (R-SH) provide a robust and powerful read-out of systemic oxidative stress. In this study, we aimed to establish serum levels of free thiols and explore associations between free thiols and demographic, clinical, and biochemical parameters related to obesity and the risk for developing CVD in both pre- and postmenopausal women. Serum free thiols were measured in a cohort consisting of healthy pre- (n = 223) and postmenopausal (n = 118) Omani women. Postmenopausal women had significantly lower levels of serum free thiols as compared to premenopausal women (762.9 ± 85.3 vs. 780 ± 80.9 μM, age-adjusted p < 0.001). Women′s age was positively associated with serum free thiol levels in premenopausal women (β = 0.36, p = 0.002), whereas an inverse association was observed in postmenopausal women (β = −0.29, p = 0.002). Homocysteine levels were significantly inversely associated with serum free thiol levels in both pre- (β = −0.19, p = 0.005) and postmenopausal (β = −0.20, p = 0.032) women, independent from known cardiovascular risk factors. In this study, we show that postmenopausal women are affected by increased systemic oxidative stress, which independently associates with homocysteine levels. Full article
(This article belongs to the Special Issue Redox Signaling in Metabolic and Age-Related Diseases)
Show Figures

Figure 1

Review

Jump to: Research

14 pages, 1185 KiB  
Review
Basic Concepts on the Role of Nuclear Factor Erythroid-Derived 2-Like 2 (Nrf2) in Age-Related Diseases
by Fabiane Valentini Francisqueti-Ferron, Artur Junio Togneri Ferron, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Mariane Róvero Costa, Cristina Schmitt Gregolin, Fernando Moreto, Ana Lúcia A. Ferreira, Igor Otávio Minatel and Camila Renata Correa
Int. J. Mol. Sci. 2019, 20(13), 3208; https://doi.org/10.3390/ijms20133208 - 29 Jun 2019
Cited by 42 | Viewed by 8070
Abstract
The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is one of the most important oxidative stress regulator in the human body. Once Nrf2 regulates the expression of a large number of cytoprotective genes, it plays a crucial role in the prevention [...] Read more.
The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is one of the most important oxidative stress regulator in the human body. Once Nrf2 regulates the expression of a large number of cytoprotective genes, it plays a crucial role in the prevention of several diseases, including age-related disorders. However, the involvement of Nrf2 on these conditions is complex and needs to be clarified. Here, a brief compilation of the Nrf2 enrollment in the pathophysiology of the most common age-related diseases and bring insights for future research on the Nrf2 pathway is described. This review shows a controversial response of this transcriptional factor on the presented diseases. This reinforces the necessity of more studies to investigate modulation strategies for Nrf2, making it a possible therapeutic target in the treatment of age-related disorders. Full article
(This article belongs to the Special Issue Redox Signaling in Metabolic and Age-Related Diseases)
Show Figures

Figure 1

Back to TopTop